fda warning letter compounding semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of September 2, 2025: U.S. compounding
Description
Take home message Retatrutide is the most effective weight-loss medication tested so far, with 28.7% body-weight loss reported at the highest dose in TRIUMPH-4
With an average potential cost of $1000 per month for the Ozempic for weight loss treatment, its important to budget accordingly
Due to the lack of targeted research, its not possible to definitively determine whether GLP-1 drugs are completely safe or unsafe for those with hemophilia
Second, increased energy expenditure burns more calories at rest
Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ
